ETF Battles: Which Biotech Stock ETF is the Better Choice? - It's IBB vs. XBI!
Send us Fan Mail
In this episode of ETF Battles, you'll watch an audience requested biotech clash between the iShares Biotechnology ETF (IBB) vs. the SPDR S&P Biotech ETF (XBI). Which biotech stock fund is the better choice?
Ron DeLegge @ETFguide referees this biotech duel with guest judges Jessica Ferringer from ETF.com and Eric Balchunas at Bloomberg sharing their research insights.
Each ETF is judged against the other in key categories like cost, exposure strategy, performance, yield and a mystery category. Find out who wins the battle!
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.